Physician profile
Reece Moore
NPI 1104407980
$1,372.07
in general payments reported to CMS, 2019-2025
9 companies · $761 in 2025
The $761 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $132 · 2024: $479 · 2025: $761.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,372.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $313.87 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Stryker Corporation | $276.40 | 2024-2025 | 1788, N/A, Na |
| Kerecis Limited | $166.17 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Davol INC. | $153.22 | 2023-2025 | Phasix Mesh, Arista |
| Avita Medical Americas, LLC | $149.92 | 2025 | Recell |
| Solventum Corporation | $115.25 | 2025 | Prevena, V.A.C. Veraflo Cleanse Choice, V.A.C.Ulta |
| Depuy Synthes Sales INC. | $100.43 | 2024 | Trumatch |
| Mentor Worldwide LLC | $61.96 | 2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Axogen | $34.85 | 2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reece Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.